Mutations in long-chain 3-hydroxyacyl coenzyme A dehydrogenase are associated with placental maternal floor infarction/massive perivillous fibrin deposition

Pediatric and Developmental Pathology

Volumn 15, Issue 5, 2012, Pages 368-374

  Griffin, Adrienne Carruth ^a   Strauss, Arnold W ^b   Bennett, Michael J ^a,c   Ernst, Linda M ^a,c,d  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

^c CHILDREN S HOSPITAL OF PHILADELPHIA   (United States)

^d NORTHWESTERN UNIVERSITY   (United States)

Author keywords

Fatty acid oxidation defects; HADHA mutations; Long chain 3 hydroxyacyl coenzyme A deficiency; Massive perivillous fibrin deposition; Maternal floor infarct

Indexed keywords

3 HYDROXYACYL COENZYME A DEHYDROGENASE; DNA; MITOCHONDRIAL PROTEIN;

AMNIOCENTESIS; AMNION FLUID ANALYSIS; ARTICLE; AUTOPSY; DNA EXTRACTION; DOPPLER FLOWMETRY; ENZYME DEFICIENCY; EXON; FEMALE; FIBRIN DEPOSITION; GENE MUTATION; GENE SEQUENCE; GENETIC ASSOCIATION; GESTATIONAL AGE; HETEROZYGOSITY; HOMOZYGOSITY; HUMAN; HUMAN TISSUE; INCIDENCE; INFANT; INFARCTION; INTRON; MALE; MICROGNATHIA; NEWBORN DEATH; PATHOGENESIS; PLACENTA; PLACENTA DISORDER; PLACENTAL MATERNAL FLOOR INFARCTION; PREMATURE FETUS MEMBRANE RUPTURE; PRIORITY JOURNAL; RETROSPECTIVE STUDY; STILLBIRTH; ULTRASOUND;

3-HYDROXYACYL COA DEHYDROGENASES; CARDIOMYOPATHIES; FEMALE; HUMANS; INFANT, NEWBORN; LIPID METABOLISM, INBORN ERRORS; MALE; MULTIENZYME COMPLEXES; MUTATION; PERIPHERAL NERVOUS SYSTEM DISEASES; PLACENTA DISEASES; PREGNANCY; RETINITIS PIGMENTOSA; STILLBIRTH;

EID: 84870047889     PISSN: 10935266     EISSN: 16155742     Source Type: Journal    
DOI: 10.2350/12-05-1198-OA.1     Document Type: Article

References (33)

1. Katzman PJ, Genest DR. Maternal floor infarction and massive perivillous fibrin deposition: histological definitions, association with intrauterine fetal growth restriction, and risk of recurrence. Pediatr Dev Pathol 2002;5:159-164. (Pubitemid 34475448)
2. Adams-Chapman I, Vaucher YE, Bejar RF, Benirschke K, Baergen RN, Moore TR. Maternal floor infarction of the placenta: association with central nervous system injury and adverse neurodevelopmental outcome. J Perinatol 2002;22:236-241. (Pubitemid 34461103)
3. Andres RL, Kuyper W, Resnik R, Piacquadio KM, Benirschke K. The association of maternal floor infarction of the placenta with adverse perinatal outcome. Am J Obstet Gynecol 1990;163:935-938. (Pubitemid 20328764)
4. Clewell WH, Manchester DK. Recurrent maternal floor infarction: a preventable cause of fetal death. Am J Obstet Gynecol 1983;147: 346-347. (Pubitemid 13015822)
5. Redline RW, Jiang JG, Shah D. Discordancy for maternal floor infarction in dizygotic twin placentas. Hum Pathol 2003;34:822-824. (Pubitemid 37040623)
6. Naeye RL. Maternal floor infarction. Hum Pathol 1985;16:823-828. (Pubitemid 15040817)
7. Nickel RE. Maternal floor infarction: an unusual cause of intrauterine growth retardation. Am J Dis Child 1988;142:1270-1271.
8. Waters BL, Ashikaga T. Significance of perivillous fibrin/oid deposition in uterine evacuation specimens. Am J Surg Pathol 2006; 30:760-765. (Pubitemid 44265003)
9. Benirschke K, Driscoll S. Pathology of the Human Placenta. New York: Springer-Verlag, 1967.
10. Fuke Y, Aono T, Imai S, Suehara N, Fujita T, Nakayama M. Clinical significance and treatment of massive intervillous fibrin deposition associated with recurrent fetal growth retardation. Gynecol Obstet Invest 1994;38:5-9. (Pubitemid 24203858)
11. Bendon RW, Hommel AB. Maternal floor infarction in autoimmune disease: two cases. Pediatr Pathol Lab Med 1996;16:293-297. (Pubitemid 26109270)
12. Chang P, Millar D, Tsang P, Lim K, Houlihan E, Stephenson M. Intravenous immunoglobulin in antiphospholipid syndrome and maternal floor infarction when standard treatment fails: a case report. Am J Perinatol 2006;23:125-129.
13. Hung NA, Jackson C, Nicholson M, Highton J. Pregnancy-related polymyositis and massive perivillous fibrin deposition in the placenta: are they pathogenetically related? Arthritis Rheum 2006; 55:154-156. (Pubitemid 43235142)
14. Sebire NJ, Backos M, El Gaddal S, Goldin RD, Regan L. Placental pathology, antiphospholipid antibodies, and pregnancy outcome in recurrent miscarriage patients. Obstet Gynecol 2003;101:258-263. (Pubitemid 36170126)
15. Sebire NJ, Backos M, Goldin RD, Regan L. Placental massive perivillous fibrin deposition associated with antiphospholipid antibody syndrome. BJOG 2002;109:570-573. (Pubitemid 37338000)
16. Gogia N, Machin GA. Maternal thrombophilias are associated with specific placental lesions. Pediatr Dev Pathol 2008;11:424-429.
17. Katz VL, DiTomasso J, Farmer R, Carpenter M. Activated protein C resistance associated with maternal floor infarction treated with low-molecular-weight heparin. Am J Perinatol 2002;19:273-277. (Pubitemid 34847568)
18. Svensson AM, Waters BL, Laszik ZG, et al. The protein C system in placental massive perivillous fibrin deposition. Blood Coagul Fibrinolysis 2004;15:491-495. (Pubitemid 39180234)
19. Robb JA, Benirschke K, Mannino F, Voland J. Intrauterine latent herpes simplex virus infection: II. Latent neonatal infection. Hum Pathol 1986;17:1210-1217. (Pubitemid 17023674)
20. Matern D, Shehata BM, Shekhawat P, Strauss AW, Bennett MJ, Rinaldo P. Placental floor infarction complicating the pregnancy of a fetus with long-chain 3-hydroxy-acyl-CoA dehydrogenase (LCHAD) deficiency. Mol Genet Metab 2001;72:265-268. (Pubitemid 34171445)
21. Tyni T, Pihko H. Long-chain 3-hydroxy-acyl-CoA dehydrogenase deficiency. Acta Paediatr 1999;88:237-245.
22. L IJ, Ruiter JP, Hoovers JM, Jakobs ME, Wanders RJ. Common missense mutation G1528C in long-chain 3-hydroxy-acyl-CoA dehydrogenase deficiency: characterization and expression of the mutant protein, mutation analysis on genomic DNA and chromosomal localization of the mitochondrial trifunctional protein alpha subunit gene. J Clin Invest 1996;98:1028-1033.
23. L IJ, Wanders RJ, Ushikubo S, Kamijo T, Hashimoto T. Molecular basis of long-chain 3-hydroxyacyl-CoA dehydrogenase deficiency: identification of the major disease-causing mutation in the alpha-subunit of the mitochondrial trifunctional protein. Biochim Biophys Acta 1994;1215:347-350.
24. Ibdah JA, Bennett MJ, Rinaldo P, et al. A fetal fatty-acid oxidation disorder as a cause of liver disease in pregnant women. N Engl J Med 1999;340:1723-1731. (Pubitemid 29252600)
25. Oey NA, den Boer ME, Ruiter JP, et al. High activity of fatty acid oxidation enzymes in human placenta: implications for fetalmaternal disease. J Inherit Metab Dis 2003;26:385-392. (Pubitemid 37045446)
26. Rakheja D, Bennett MJ, Foster BM, Domiati-Saad R, Rogers BB. Evidence for fatty acid oxidation in human placenta, and the relationship of fatty acid oxidation enzyme activities with gestational age. Placenta 2002;23:447-450. (Pubitemid 41110509)
27. Sims HF, Brackett JC, Powell CK, et al. The molecular basis of pediatric long chain 3-hydroxyacyl-CoA dehydrogenase deficiency associated with maternal acute fatty liver of pregnancy. Proc Natl Acad Sci USA 1995;92:841-845.
28. Tyni T, Ekholm E, Pihko H. Pregnancy complications are frequent in long-chain 3-hydroxyacyl-coenzyme A dehydrogenase deficiency. Am J Obstet Gynecol 1998;178:603-608. (Pubitemid 28207518)
29. Browning MF, Levy HL, Wilkins-Haug LE, Larson C, Shih VE. Fetal fatty acid oxidation defects and maternal liver disease in pregnancy. Obstet Gynecol 2006;107:115-120.
30. den Boer ME, Ijlst L, Wijburg FA, et al. Heterozygosity for the common LCHAD mutation (1528g>C) is not a major cause of HELLP syndrome and the prevalence of the mutation in the Dutch population is low. Pediatr Res 2000;48:151-154. (Pubitemid 30497330)
31. Holub M, Bodamer OA, Item C, Muhl A, Pollak A, Stockler-Ipsiroglu S. Lack of correlation between fatty acid oxidation disorders and haemolysis, elevated liver enzymes, low platelets (HELLP) syndrome? Acta Paediatr 2005;94:48-52. (Pubitemid 40127933)
32. Jones PM, Quinn R, Fennessey PV, et al. Improved stable isotope dilution-gas chromatography-mass spectrometry method for serum or plasma free 3-hydroxy-fatty acids and its utility for the study of disorders of mitochondrial fatty acid beta-oxidation. Clin Chem 2000;46:149-155. (Pubitemid 30104236)
33. Isaacs JD Jr, Sims HF, Powell CK, et al. Maternal acute fatty liver of pregnancy associated with fetal trifunctional protein deficiency: molecular characterization of a novel maternal mutant allele. Pediatr Res 1996;40:393-398. (Pubitemid 26282571)